BNP Paribas Financial Markets
AGN

BNP Paribas Financial Markets’s Allergan Inc AGN Stock Holding History

BNP Paribas Financial Markets’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-464,309
Closed -$98.7M – 3712
2014
Q4 		$98.7M Buy
464,309
+232,660
+100% +$46.3M 0.35% 51
2014
Q3 		$41.3M Buy
231,649
+1,820
+0.8% +$302K 0.04% 200
2014
Q2 		$38.9M Buy
229,829
+96,249
+72% +$15M 0.04% 179
2014
Q1 		$22.2M Sell
133,580
-26,326
-16% -$3.21M 0.02% 267
2013
Q4 		$17.8M Sell
159,906
-14,611
-8% -$1.4M 0.01% 318
2013
Q3 		$15.8M Buy
174,517
+138,759
+388% +$12.5M 0.01% 379
2013
Q2 		$3.01M Buy
+35,758
New +$3.71M ﹤0.01% 628

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

BNP Paribas Financial Markets's AGN Position: Q1 2015 in Review

BNP Paribas Financial Markets sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 464,309 shares — an estimated $98.7M sold.

BNP Paribas Financial Markets first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $98.7M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • BNP Paribas Financial Markets reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 464,309 Allergan Inc shares in Q1 2015, an estimated $98.7M.
  • BNP Paribas Financial Markets first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • BNP Paribas Financial Markets's Allergan Inc position peaked at $98.7M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2015, filed 15 May 2015.